OCT Angiography Drived Alterations in Thyroid-associated Orbitopathy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

68 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-12-09

Study Completion Date

2025-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this observational study is to evaluate retinal microvascular alterations in patients with thyroid-associated orbitopathy (TAO) using optical coherence tomography angiography (OCTA). The specific objectives are:

* To assess the impact of extraocular muscle (EOM) enlargement on vessel density in the superficial and deep retinal capillary plexuses in patients with TAO.
* To determine the effect of increased orbital fat volume on superficial and deep retinal vessel density in TAO.
* To evaluate the relationship between disease activity, as measured by the Clinical Activity Score (CAS), and retinal microvascular density in patients with TAO.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Optic Disc, Macula, and Retinal Nerve Fiber Layer Measurements Obtained by OCT in Thyroid Associated Ophthalmopathy

NCT02766660

Thyroid Associated Ophthalmopathy

COMPLETED NA

Wide Field OCTA in Ocular Diseases

NCT07298174

NOT_YET_RECRUITING

Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography

NCT06074731

Retinal Disease Diabetic Retinopathy Macular Degeneration

RECRUITING

Imaging of the Angiofibrotic Switch in Neovascular AMD

NCT03838679

UNKNOWN

Retinal Thickness Analysis Using Optical Coherence Tomography

NCT00797134

Diabetic Retinopathy

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After obtaining written informed consent and confirming eligibility, all patients with TAO and controls underwent a detailed medical history review and ophthalmologic examination. Collected clinical data included age and sex. For patients with TAO collected data also oncluded duration of Graves' hyperthyroidism (GH) and orbitopathy (GO), as well as serum levels of thyroid-stimulating hormone (TSH), triiodothyronine (T3), thyroxine (T4), thyrotropin receptor antibodies (TRAb), and anti-thyroid peroxidase antibodies (anti-TPO). For all participants a comprehensive ophthalmologic assessment was performed, which included evaluation of the periocular region, ocular motility, pupillary reflexes, best-corrected visual acuity (BCVA), slit-lamp biomicroscopy, intraocular pressure (IOP) measurement using Goldmann applanation tonometry in primary and upward gaze, exophthalmometry with a Hertel device, and dilated fundus examination.

Disease activity in patientss with TAO was assessed using the Clinical Activity Score (CAS), following the European Group on Graves' Orbitopathy (EUGOGO) guidelines.

MRI images of orbit in TAO patients acquired using 1.5T and 3T scanners (Siemens Magnetom Avanto Fit 124 and Magnetom Skyra, Siemens Healthcare, Germany) during TAO evaluation were reviewed manually by an experienced radiologist using the PACS imaging software (Sectra 126 IDS7, Version 24.1, Linköping, Sweden). Measurements were performed on T1- and T2-weighted images in both coronal and axial planes.The maximum diameter of each of the four rectus muscles (medial, lateral, superior, and inferior) was measured at its thickest midpoint. Horizontal diameters of the medial and lateral rectus muscles were obtained on axial images, while vertical diameters of the superior and inferior rectus muscles were measured on coronal sections.

Exophthalmos was determined as the perpendicular distance between the anterior surface of the cornea and the line connecting both lateral orbital rims on the slice where the globe and optic nerve were most clearly visualized. Orbital fat thickness was measured as the maximum distance from the lateral border of the medial rectus muscle to the medial orbital wall. Based on radiological characteristics, patients with TAO were classified into three subtypes: fat-predominant, muscle-predominant, and mixed type.

Optical coherence tomography angiography (OCTA) was performed in all paticipants (patients with TAO and controls) using the OptoVue XR Avanti device equipped with the split-spectrum amplitude-decorrelation angiography (SSADA) algorithm (software version 2014.2.0.90), with the Angio Retina 6×6 mm protocol. Retinal vessel density was analyzed at two vascular levels-the superficial capillary plexus and the deep capillary plexus. Following the instrument's standardized protocol, the macula was divided into nine regions: a central foveal zone, parafoveal ring, and perifoveal ring, each subdivided into superior, inferior, nasal, and temporal quadrants. The foveal avascular zone was also measured.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thyroid Associated Orbitopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with TAO

The study cohort consisted of patients diagnosed with TAO of varying activity and duration. All subjects were Caucasian without other significant ocular comorbidities that could confound retinal microvascular measurements. Patients with TAO were classified based on MRI characteristics into three subgroups: fat-predominant, muscle-predominant, and mixed type.

No interventions assigned to this group

Control group

Participants without TAO or other significant ocular comorbidities were included. All subjects were Caucasian and were age- and gender-matched to the TAO patient group.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patients (≥18 years) of both sexes with a confirmed diagnosis of TAO treated at University Hospital Osijek.

Exclusion Criteria

* anterior segment pathology (e.g., central keratopathy),
* primary open- or closed-angle glaucoma,
* posterior segment disorders (e.g., diabetic retinopathy, age-related macular degeneration, retinal vascular occlusion),
* previous ocular trauma or uveitis,
* refractive errors exceeding ±6.0 Diopter sphere or ±3.0 Diopter cylinder
* media opacities that compromised angio optical OCTA image quality,
* contraindication for orbital MRI

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes